The Pharmacogenomics Journal, 23 (5), 105-111
Given that stem cells are core drivers of organismal aging, health and longevity, a greater understanding of these NRF2-based aspects may make it possible one day to rejuvenate tissues in older individuals, thereby increasing human healthspan and perhaps lifespan
TB-500 protocol considerations Reported dosing in the research literature: Starting dose: 500 mcg daily, subcutaneous injection Titration: Increase by 100 to 150 mcg every two weeks as tolerated Target dose: 750 to 1000 mcg daily by weeks five through twelve Weekly total: Approximately 5 mg per week at full dose Cycle length: Eight to twelve weeks, with optional extension to sixteen weeks TB-500 is typically administered once daily via subcutaneous injection, with consistent timing and systematic site rotation
Sobo concludes: At our Stamford clinic, our goal is not just to control symptoms but to help patients reclaim stability and vitality
doi: 10.3390/nu16010154 114
